Found: 14
Select item for more details and to access through your institution.
HER2 Targeting in Early Breast Cancer: More Options and More Questions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 293
- By:
- Publication type:
- Article
Breast Cancer: Never Too Young for a Functional Assessment?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 9, p. 811
- By:
- Publication type:
- Article
Metabolic Effects of Hormone Deprivation Therapy: Weighing the Evidence.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 846
- By:
- Publication type:
- Article
Randomized psychosocial interventions for breast cancer: impact on life purpose.
- Published in:
- 2016
- By:
- Publication type:
- journal article
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 69, doi. 10.1007/s10549-017-4550-8
- By:
- Publication type:
- Article
Single‐fraction radiosurgery for the treatment of spinal breast metastases.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 10, p. 2244
- By:
- Publication type:
- Article
Rapid response to 2′-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
- Published in:
- American Journal of Hematology, 1988, v. 27, n. 1, p. 60, doi. 10.1002/ajh.2830270114
- By:
- Publication type:
- Article
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 2, p. 117, doi. 10.1016/j.clcc.2011.03.008
- By:
- Publication type:
- Article
Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy.
- Published in:
- 2011
- By:
- Publication type:
- Erratum
Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy: A Single Institutional Experience With 359 Cases.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 6, p. 1431, doi. 10.1002/cncr.24876
- By:
- Publication type:
- Article
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2013, v. 108, n. 4, p. 236, doi. 10.1002/jso.23392
- By:
- Publication type:
- Article
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1302, doi. 10.1093/jnci/djad078
- By:
- Publication type:
- Article
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article